A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A phase 2 trial of Daunorubicin, Cytarabine and Eltrombopag in Leukaemia, run by Novartis Pharmaceuticals, completed.
Overview
A Safety and Efficacy Study of Eltrombopag in Subjects With AML is a phase 2 interventional study registered as NCT01890746 by Novartis Pharmaceuticals, with 148 participants recorded, started 2013-09-05 and reaching its primary completion in 2015-03-13. Interventions recorded: Daunorubicin, Cytarabine, Eltrombopag, Placebo. Conditions recorded: Acute Leukaemia.
Linked to the drug Eltrombopag because the registry names it among its interventions and Leukaemia among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialPhase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia
Shares Eltrombopag, Leukaemia (all types) and the tag pipeline.
- TrialStudy Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy
Shares Eltrombopag and the tag pipeline.
- TrialCombination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
Shares Daunorubicin, Cytarabine, Leukaemia (all types) and the tag pipeline.
- TrialClofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Shares Daunorubicin, Cytarabine and the tag pipeline.
- TrialTreatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
Shares Daunorubicin, Cytarabine, Leukaemia (all types) and the tag pipeline.
- TrialResponse-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Shares Daunorubicin, Cytarabine, Leukaemia (all types) and the tag pipeline.
- TrialCombination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
Shares Daunorubicin, Cytarabine, Leukaemia (all types) and the tag pipeline.
- TrialA Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia
Shares Cytarabine, Leukaemia (all types) and the tag pipeline.